Why the study?
No national guidelines exist regarding BMI in pediatric heart transplant and outcomes data are limited, leaving candidacy decisions to individual institutions or case-by-case evaluation.
Should obesity be used as an absolute contraindication for pediatric heart transplant candidacy?
Should obesity be used as an absolute contraindication for pediatric heart transplant candidacy?
There is insufficient evidence to support using BMI cutoffs as an absolute contraindication for pediatric heart transplantation, and doing so raises significant ethical and health equity concerns.
Avoid BMI cutoffs as absolute contraindications for pediatric heart transplant; leaves open needs for prospective equity-focused outcome data.
Background Inclusion of BMI as criterion in the determination of heart transplant candidacy in children is a clinical and ethical challenge. Childhood obesity is increasing and children with heart disease are not spared. Currently, many adult heart transplant centers consider class II obesity and higher (BMI > 35 kg/m 2 ) to be a relative contraindication for transplantation due to risk of poor outcome after transplant. No national guidelines exist regarding consideration of BMI in pediatric heart transplant and outcomes data are limited. This leaves decisions about transplant candidacy in obese pediatric patients to individual institutions or on a case‐by‐case basis, allowing for bias and inequity. Methods We review (a) the prevalence of childhood obesity, including among heart transplant candidates, (b) the lack of existing BMI guidelines, and (c) relevant literature on BMI and pediatric heart transplant outcomes. We discuss the ethical considerations of using obesity as a criterion using the principles of utility, justice, and respect for persons. Results Existing transplant outcomes data do not show that obese children have different or poor enough outcomes compared to non‐obese children to warrant exclusion. Moreover, obesity in the United States is unequally distributed by race and socioeconomic status. Children already suffering from health disparities are therefore doubly penalized if obesity denies them access to life‐saving transplant. Conclusion Insufficient data exist to support using any BMI cutoff as an absolute contraindication for heart transplant in children. Attention should be paid to health equity issues when considering excluding a patient for transplant based on obesity.
No takes yet. Share an insight, caveat, or question.
Berkman et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: